Mumbai, India

Julius Mascarenhas

This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Aktiengesellschaft. Active years: 1986.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Julius Mascarenhas. Retrieved from https://idiyas.com/inventor/julius-mascarenhas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 1986

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Julius Mascarenhas

Introduction

Julius Mascarenhas is a notable inventor based in Bombay, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with therapeutic properties. His work has led to the creation of a patent that showcases his innovative approach to drug design.

Latest Patents

Julius Mascarenhas holds a patent for "9,10-substituted-2-mesitylimino-3-alkyl-3,4,6,7-tetrahydro-2H-pyrimido-(6,1-a)isoquinoline-4-ones and salts thereof having hypotensive and vasodilating properties." This invention highlights his focus on developing medications that can effectively manage blood pressure and improve vascular health.

Career Highlights

Throughout his career, Julius has been associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work at Hoechst has allowed him to collaborate with other talented professionals and contribute to groundbreaking research in drug development.

Collaborations

Julius Mascarenhas has worked alongside esteemed colleagues such as Bansi Lal and Alihussein N Dohadwalla. These collaborations have enriched his research and expanded the impact of his inventions in the medical field.

Conclusion

Julius Mascarenhas is a distinguished inventor whose work has advanced the pharmaceutical industry. His innovative patent reflects his commitment to improving health outcomes through scientific research and collaboration.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…